Allspring Global Investments Holdings, LLC Silverback Therapeutics, Inc. Transaction History

Allspring Global Investments Holdings, LLC

  • $59.4 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024
SELL
N/A
-1,624 Reduced 52.45%
1,472 $0
Q4 2023

Jan 25, 2024
BUY
N/A
3,096 New
3,096 $0
Q1 2022

May 02, 2022
BUY
$3.51 - $6.74 $142,509 - $273,650
40,601 New
40,601 $142,000

Others Institutions Holding SBTX

# of Institutions
122
Shares Held
61.4M
Call Options Held
1.37M
Put Options Held
83.8K
View Full List

About Silverback Therapeutics, Inc.

SBTX Quotes by TradingView
  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email